Literature DB >> 22585951

Day-night dip and early-morning surge in blood pressure in hypertension: prognostic implications.

Paolo Verdecchia1, Fabio Angeli, Giovanni Mazzotta, Marta Garofoli, Elisa Ramundo, Giorgio Gentile, Giuseppe Ambrosio, Gianpaolo Reboldi.   

Abstract

We investigated the relationship between the day-night blood pressure (BP) dip and the early morning BP surge in an cohort of 3012 initially untreated subjects with essential hypertension. The day-night reduction in systolic BP showed a direct association with the sleep trough (r = 0.564; P < 0.0001) and the preawakening (r = 0.554; P < 0.0001) systolic BP surge. Over a mean follow-up period of 8.44 years, 268 subjects developed a major cardiovascular event (composite of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, and heart failure requiring hospitalization) and 220 subjects died. In a Cox model, after adjustment for predictive covariates, including age, sex, diabetes mellitus, cigarette smoking, total cholesterol, left ventricular hypertrophy on ECG, estimated glomerular filtration rate, and average 24-hour systolic BP, a blunted sleep trough (≤ 19.5 mm Hg; quartile 1) and preawakening (≤ 9.5 mm Hg; quartile 1) BP surge was associated with an excess risk of events (hazard ratio, 1.66 [95% CI, 1.14-2.42]; P = 0.009; hazard ratio, 1.71 [95% CI, 1.12-2.71]; P = 0.013). After adjustment for the same covariates, neither the dipping pattern nor the measures of early morning BP surge were independent predictors of mortality. In conclusion, in initially untreated subjects with hypertension, a blunted day-night BP dip was associated with a blunted morning BP surge and vice versa. In these subjects, a blunted morning BP surge was an independent predictor of cardiovascular events, whereas an excessive BP surge did not portend an increased risk of events.

Entities:  

Mesh:

Year:  2012        PMID: 22585951     DOI: 10.1161/HYPERTENSIONAHA.112.191858

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  80 in total

1.  Daily environmental differences in blood pressure and heart rate variability in healthy premenopausal women.

Authors:  Gary D James; Dana H Bovbjerg; Leah A Hill
Journal:  Am J Hum Biol       Date:  2014-08-25       Impact factor: 1.937

Review 2.  Blood pressure regulation VII. The "morning surge" in blood pressure: measurement issues and clinical significance.

Authors:  Greg Atkinson; Alan M Batterham; Kazuomi Kario; Chloe E Taylor; Helen Jones
Journal:  Eur J Appl Physiol       Date:  2013-07-18       Impact factor: 3.078

Review 3.  Does blood pressure variability contribute to risk stratification? Methodological issues and a review of outcome studies based on home blood pressure.

Authors:  Kei Asayama; Fang-Fei Wei; Yan-Ping Liu; Azusa Hara; Yu-Mei Gu; Rudolph Schutte; Yan Li; Lutgarde Thijs; Jan A Staessen
Journal:  Hypertens Res       Date:  2014-10-16       Impact factor: 3.872

Review 4.  Blood pressure variability: assessment, predictive value, and potential as a therapeutic target.

Authors:  Gianfranco Parati; Juan Eugenio Ochoa; Carolina Lombardi; Grzegorz Bilo
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

5.  Race, plasma renin activity, and morning blood pressure surge--results from the Dietary Approaches to Stop Hypertension trial.

Authors:  Finnian R Mc Causland; Ciaran J McMullan; Frank M Sacks; John P Forman
Journal:  Am J Hypertens       Date:  2013-03-08       Impact factor: 2.689

6.  [J curve: when lowering blood pressure becomes a hazard?].

Authors:  J Slany
Journal:  Internist (Berl)       Date:  2013-03       Impact factor: 0.743

Review 7.  Assessment and management of blood-pressure variability.

Authors:  Gianfranco Parati; Juan E Ochoa; Carolina Lombardi; Grzegorz Bilo
Journal:  Nat Rev Cardiol       Date:  2013-02-12       Impact factor: 32.419

Review 8.  Ambulatory blood pressure improves prediction of cardiovascular risk: implications for better antihypertensive management.

Authors:  Lawrence R Krakoff
Journal:  Curr Atheroscler Rep       Date:  2013-04       Impact factor: 5.113

Review 9.  Labile hypertension: a new disease or a variability phenomenon?

Authors:  Elias Sanidas; Charalampos Grassos; Dimitrios P Papadopoulos; Maria Velliou; Kostas Tsioufis; Marina Mantzourani; Despoina Perrea; Dimitrios Iliopoulos; John Barbetseas; Vasilios Papademetriou
Journal:  J Hum Hypertens       Date:  2019-01-15       Impact factor: 3.012

10.  The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease.

Authors:  Mai Yanagi; Kouichi Tamura; Tetsuya Fujikawa; Hiromichi Wakui; Tomohiko Kanaoka; Masato Ohsawa; Kengo Azushima; Akinobu Maeda; Hiroyuki Kobori; Satoshi Umemura
Journal:  Hypertens Res       Date:  2012-11-15       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.